Humanizing AI-native biotech
Nabla Bio designs protein therapeutics with AI. Spun out of George Church's lab at Harvard, the company pairs generative protein design with wet-lab measurement to reach targets conventional antibody discovery can't, and has struck collaborations with AstraZeneca, Bristol Myers Squibb and Takeda. G—W developed the visual identity, website and brand extensions that give the science a human face.
NaniteConstructing an identity from the smallest of building blocks